IDIBELL on the media
The integrity of the blood-brain barrier depends on a protein that is altered in some neurodegenerative diseases
A study led by the Bellvitge Biomedical Research Institute (IBIDELL) and the University of Barcelona reveals that the TDP-43 protein is essential for forming a stable and mature blood vessel network in the central nervous system.
A new tool based on Artificial Intelligence will improve brain tumour diagnosis
This study demonstrates the potential of the DISCERN application to aid medical decisions for the diagnosis of brain tumours using standard MRI.
8M: Every 8 minutes a woman dies of cardiovascular disease
This 8M, IDIBELL wants to focus on cardiovascular diseases in women
The Spanish Association Against Cancer in Barcelona finances two IDIBELL projects with 445,000 euros
Two IDIBELL projects, one led by Dr. Marta Crous and the other by Dr. Bárbara Rivera, have been selected to receive funding from the Association Against Cancer in Barcelona.
March 4, International Human Papillomavirus Awareness Day
Worldwide, more than half a million cancers are caused by HPV. HPV is the cause of all cervical cancers and also some cancers of the vulva, penis, vagina, anus and oropharynx.
Ander Gómez, new IDIBELL’s Managing Director
Ander Gómez will take over from Rosa Benet as Managing Director.
Maria Molina, new Scientific Director of IDIBELL
Maria Molina will take over from Fernando Fernández Aranda as Scientific Director.
Endocrine disruptors may increase the risk of endometrial cancer
A study reveals an association between mixtures of environmental pollutants and an increased risk of developing endometrial cancer
